ID   KPCB_HUMAN              Reviewed;         671 AA.
AC   P05771; C5IFJ8; O43744; P05127; Q15138; Q93060; Q9UE49; Q9UE50;
AC   Q9UEH8; Q9UJ30; Q9UJ33;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   05-OCT-2010, entry version 147.
DE   RecName: Full=Protein kinase C beta type;
DE            Short=PKC-B;
DE            Short=PKC-beta;
DE            EC=2.7.11.13;
GN   Name=PRKCB; Synonyms=PKCB, PRKCB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-II).
RX   MEDLINE=86289426; PubMed=3755548; DOI=10.1126/science.3755548;
RA   Coussens L., Parker P.J., Rhee L., Yang-Feng T.L., Chen E.,
RA   Waterfield M.D., Francke U., Ullrich A.;
RT   "Multiple, distinct forms of bovine and human protein kinase C suggest
RT   diversity in cellular signaling pathways.";
RL   Science 233:859-866(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS BETA-I AND BETA-II).
RX   MEDLINE=88030028; PubMed=3666134; DOI=10.1016/0014-5793(87)80524-0;
RA   Kubo K., Ohno S., Suzuki K.;
RT   "Primary structures of human protein kinase C beta I and beta II
RT   differ only in their C-terminal sequences.";
RL   FEBS Lett. 223:138-142(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (APR-2009) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=99425270; PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R.,
RA   Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L.,
RA   Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E.,
RA   Harris P.C., Venter J.C., Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from
RT   human chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-69.
RX   MEDLINE=95186059; PubMed=7880442; DOI=10.1089/dna.1995.14.213;
RA   Mahajna J., King P., Parker P., Haley J.;
RT   "Autoregulation of cloned human protein kinase C beta and gamma gene
RT   promoters in U937 cells.";
RL   DNA Cell Biol. 14:213-222(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-58.
RX   MEDLINE=92210589; PubMed=1556124;
RA   Niino Y.S., Ohno S., Suzuki K.;
RT   "Positive and negative regulation of the transcription of the human
RT   protein kinase C beta gene.";
RL   J. Biol. Chem. 267:6158-6163(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-57.
RX   MEDLINE=93015985; PubMed=1400396;
RA   Obeid L.M., Blobe G.C., Karolak L.A., Hannun Y.A.;
RT   "Cloning and characterization of the major promoter of the human
RT   protein kinase C beta gene. Regulation by phorbol esters.";
RL   J. Biol. Chem. 267:20804-20810(1992).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-19, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 97-176.
RA   Greenham J.A., Adams M.D., Doggett N.A., Mole S.E.;
RT   "The genomic structure of the human protein kinase C beta gene
RT   (PRKCB).";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 609-671.
RC   TISSUE=Fetal brain;
RX   MEDLINE=88054462; PubMed=3677994;
RA   Coussens L., Rhee L., Parker P.J., Ullrich A.;
RT   "Alternative splicing increases the diversity of the human protein
RT   kinase C family.";
RL   DNA 6:389-394(1987).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 622-671.
RX   MEDLINE=88015556; PubMed=3658678; DOI=10.1093/nar/15.17.7179;
RA   Kubo K., Ohno S., Suzuki K.;
RT   "Nucleotide sequence of the 3' portion of a human gene for protein
RT   kinase C beta-I/beta-II.";
RL   Nucleic Acids Res. 15:7179-7180(1987).
RN   [14]
RP   ENZYME REGULATION.
RX   PubMed=16103100; DOI=10.1158/0008-5472.CAN-05-0071;
RA   Graff J.R., McNulty A.M., Hanna K.R., Konicek B.W., Lynch R.L.,
RA   Bailey S.N., Banks C., Capen A., Goode R., Lewis J.E., Sams L.,
RA   Huss K.L., Campbell R.M., Iversen P.W., Neubauer B.L., Brown T.J.,
RA   Musib L., Geeganage S., Thornton D.;
RT   "The protein kinase Cbeta-selective inhibitor, Enzastaurin
RT   (LY317615.HCl), suppresses signaling through the AKT pathway, induces
RT   apoptosis, and suppresses growth of human colon cancer and
RT   glioblastoma xenografts.";
RL   Cancer Res. 65:7462-7469(2005).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-500 AND THR-504, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [16]
RP   INTERACTION WITH PHLPP1 AND PHLPP2.
RX   PubMed=18162466; DOI=10.1074/jbc.M707319200;
RA   Gao T., Brognard J., Newton A.C.;
RT   "The phosphatase PHLPP controls the cellular levels of protein kinase
RT   C.";
RL   J. Biol. Chem. 283:6300-6311(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-642, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-500 AND THR-504,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-641 AND SER-660 (ISOFORM
RP   BETA-II), AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [20]
RP   FUNCTION IN HISTONE H3 PHOSPHORYLATION, CATALYTIC ACTIVITY,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH KDM1A; PKN1 AND ANDR.
RX   PubMed=20228790; DOI=10.1038/nature08839;
RA   Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N.,
RA   Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N.,
RA   Beisenherz-Huss C., Gunther T., Buettner R., Schule R.;
RT   "Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation
RT   at histone H3K4.";
RL   Nature 464:792-796(2010).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 321-660 IN COMPLEX WITH
RP   INHIBITOR, AND PHOSPHORYLATION AT THR-500; THR-642 AND SER-661.
RX   PubMed=17115692; DOI=10.1021/bi061128h;
RA   Grodsky N., Li Y., Bouzida D., Love R., Jensen J., Nodes B.,
RA   Nonomiya J., Grant S.;
RT   "Structure of the catalytic domain of human protein kinase C beta II
RT   complexed with a bisindolylmaleimide inhibitor.";
RL   Biochemistry 45:13970-13981(2006).
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-144; MET-496 AND HIS-588.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium-activated and phospholipid-dependent
CC       serine/threonine-protein kinase involved in various processes such
CC       as regulation of the B-cell receptor (BCR) signalosome, apoptosis
CC       and transcription regulation. Plays a key role in B-cell
CC       activation and function by regulating BCR-induced NF-kappa-B
CC       activation and B-cell suvival. Required for recruitment and
CC       activation of the IKK kinase to lipid rafts and mediates
CC       phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-
CC       652', leading to activate the NF-kappa-B signaling. Involved in
CC       apoptosis following oxidative damage: in case of oxidative
CC       conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc
CC       of SHC1, leading to mitochondrial accumulation of p66Shc, where
CC       p66Shc acts as a reactive oxygen species producer. Acts as a
CC       coactivator of androgen receptor (ANDR)-dependent transcription,
CC       by being recruited to ANDR target genes and specifically mediating
CC       phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag
CC       for epigenetic transcriptional activation that prevents
CC       demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A. Also
CC       involved in triglyceride homeostasis. Serves as the receptor for
CC       phorbol esters, a class of tumor promoters.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Binds 3 calcium ions per subunit. The ions are bound to
CC       the C2 domain (By similarity).
CC   -!- ENZYME REGULATION: Activated by diacylglycerol which in turn
CC       phosphorylates a range of cellular proteins. Specifically
CC       inhibited by Enzastaurin (LY317615).
CC   -!- SUBUNIT: Interacts with PDK1 (By similarity). Interacts in vitro
CC       with PRKCBP1. Interacts with PHLPP1 and PHLPP2; both proteins
CC       mediate its dephosphorylation. Interacts with KDM1A/LSD1, PKN1 and
CC       ANDR.
CC   -!- INTERACTION:
CC       Q42384:PRL1 (xeno); NbExp=1; IntAct=EBI-706216, EBI-1382964;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus.
CC       Membrane; Peripheral membrane protein (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Beta-I; Synonyms=PRKCB1;
CC         IsoId=P05771-1; Sequence=Displayed;
CC       Name=Beta-II; Synonyms=PRKCB2;
CC         IsoId=P05771-2; Sequence=VSP_004738;
CC         Note=Phosphorylated on Thr-641 and Ser-660;
CC   -!- PTM: Phosphorylation on Thr-500 within the activation loop renders
CC       it competent to autophosphorylate. Subsequent autophosphorylation
CC       of Thr-642 maintains catalytic competence, and autophosphorylation
CC       on Ser-661 appears to release the kinase into the cytosol.
CC       Autophosphorylation on other sites i.e. in the N-terminal and
CC       hinge regions have no effect on enzyme activity (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 C2 domain.
CC   -!- SIMILARITY: Contains 2 phorbol-ester/DAG-type zinc fingers.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/prkcb1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M13975; AAA60095.1; -; mRNA.
DR   EMBL; X06318; CAA29634.1; -; mRNA.
DR   EMBL; X07109; CAA30130.1; -; mRNA.
DR   EMBL; FJ907246; ACS14045.1; -; Genomic_DNA.
DR   EMBL; AC130454; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002299; AAB97933.1; -; Genomic_DNA.
DR   EMBL; AC002299; AAB97934.1; -; Genomic_DNA.
DR   EMBL; CH471145; EAW55797.1; -; Genomic_DNA.
DR   EMBL; BC036472; AAH36472.1; -; mRNA.
DR   EMBL; X62532; CAA44393.1; -; Genomic_DNA.
DR   EMBL; S47311; AAD13852.1; -; Genomic_DNA.
DR   EMBL; D10022; BAA00912.1; -; Genomic_DNA.
DR   EMBL; AJ002799; CAA05725.1; -; Genomic_DNA.
DR   EMBL; AJ002800; CAA05725.1; JOINED; Genomic_DNA.
DR   EMBL; M18254; AAA60096.1; -; Genomic_DNA.
DR   EMBL; M18255; AAA60097.1; -; Genomic_DNA.
DR   EMBL; X05972; CAA29396.1; -; Genomic_DNA.
DR   EMBL; X05971; CAA29395.1; -; Genomic_DNA.
DR   IPI; IPI00010466; -.
DR   IPI; IPI00219628; -.
DR   PIR; B24664; KIHUC2.
DR   PIR; S00159; KIHUC1.
DR   RefSeq; NP_002729.2; -.
DR   RefSeq; NP_997700.1; -.
DR   UniGene; Hs.460355; -.
DR   PDB; 2I0E; X-ray; 2.60 A; A/B=321-661.
DR   PDBsum; 2I0E; -.
DR   ProteinModelPortal; P05771; -.
DR   SMR; P05771; 37-106, 93-168, 157-288, 339-668.
DR   IntAct; P05771; 6.
DR   MINT; MINT-240997; -.
DR   STRING; P05771; -.
DR   PhosphoSite; P05771; -.
DR   PRIDE; P05771; -.
DR   Ensembl; ENST00000321728; ENSP00000318315; ENSG00000166501.
DR   GeneID; 5579; -.
DR   KEGG; hsa:5579; -.
DR   UCSC; uc002dmc.1; human.
DR   UCSC; uc002dmd.1; human.
DR   CTD; 5579; -.
DR   GeneCards; GC16P023847; -.
DR   H-InvDB; HIX0012899; -.
DR   HGNC; HGNC:9395; PRKCB.
DR   HPA; CAB003843; -.
DR   MIM; 176970; gene.
DR   PharmGKB; PA33761; -.
DR   eggNOG; prNOG17877; -.
DR   HOVERGEN; HBG108317; -.
DR   OMA; QAHIDRE; -.
DR   OrthoDB; EOG9SN471; -.
DR   PhylomeDB; P05771; -.
DR   BRENDA; 2.7.11.13; 247.
DR   Pathway_Interaction_DB; cd8tcrdownstreampathway; Downstream signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; tcrjnkpathway; JNK signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; tcrraspathway; Ras signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Pathway_Interaction_DB; cd8tcrpathway; TCR signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Pathway_Interaction_DB; vegfr1_pathway; VEGFR1 specific signals.
DR   Reactome; REACT_13685; Synaptic Transmission.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   Reactome; REACT_604; Hemostasis.
DR   DrugBank; DB00163; Vitamin E.
DR   NextBio; 21632; -.
DR   PMAP-CutDB; P05771; -.
DR   ArrayExpress; P05771; -.
DR   Bgee; P05771; -.
DR   Genevestigator; P05771; -.
DR   GermOnline; ENSG00000166501; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0050681; F:androgen receptor binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0035403; F:histone kinase activity (H3-T6 specific); IDA:UniProtKB.
DR   GO; GO:0030374; F:ligand-dependent nuclear receptor transcrip...; IMP:UniProtKB.
DR   GO; GO:0004697; F:protein kinase C activity; TAS:ProtInc.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0042113; P:B cell activation; ISS:UniProtKB.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0042953; P:lipoprotein transport; TAS:BHF-UCL.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-k...; ISS:UniProtKB.
DR   GO; GO:0034339; P:regulation of transcription from RNA polyme...; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   GO; GO:0006350; P:transcription; IEA:UniProtKB-KW.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_Ca-dep.
DR   InterPro; IPR008973; C2_Ca/lipid-bd_dom_CaLB.
DR   InterPro; IPR018029; C2_membr_targeting.
DR   InterPro; IPR020477; C2_region.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015745; PKC.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014375; Protein_kinase_C_a/b/g.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22985:SF86; PKC; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000550; PKC_alpha; 1.
DR   PRINTS; PR00360; C2DOMAIN.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2_CaLB; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Adaptive immunity; Alternative splicing;
KW   Apoptosis; ATP-binding; Calcium; Chromatin regulator;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Immunity;
KW   Kinase; Membrane; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Repeat; Serine/threonine-protein kinase;
KW   Transcription; Transcription regulation; Transferase; Zinc;
KW   Zinc-finger.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    671       Protein kinase C beta type.
FT                                /FTId=PRO_0000055684.
FT   DOMAIN      173    260       C2.
FT   DOMAIN      342    600       Protein kinase.
FT   DOMAIN      601    671       AGC-kinase C-terminal.
FT   ZN_FING      36     86       Phorbol-ester/DAG-type 1.
FT   ZN_FING     101    151       Phorbol-ester/DAG-type 2.
FT   NP_BIND     348    356       ATP (By similarity).
FT   ACT_SITE    466    466       Proton acceptor (By similarity).
FT   METAL       186    186       Calcium 1; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       187    187       Calcium 1 (By similarity).
FT   METAL       187    187       Calcium 2 (By similarity).
FT   METAL       193    193       Calcium 2 (By similarity).
FT   METAL       246    246       Calcium 1 (By similarity).
FT   METAL       246    246       Calcium 2 (By similarity).
FT   METAL       247    247       Calcium 2; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       248    248       Calcium 1 (By similarity).
FT   METAL       248    248       Calcium 2 (By similarity).
FT   METAL       248    248       Calcium 3 (By similarity).
FT   METAL       251    251       Calcium 3 (By similarity).
FT   METAL       252    252       Calcium 3; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       254    254       Calcium 1 (By similarity).
FT   METAL       254    254       Calcium 3 (By similarity).
FT   BINDING     371    371       ATP (By similarity).
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES      16     16       Phosphoserine; by autocatalysis
FT                                (Potential).
FT   MOD_RES      17     17       Phosphothreonine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     195    195       Phosphotyrosine (By similarity).
FT   MOD_RES     314    314       Phosphothreonine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     324    324       Phosphothreonine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     500    500       Phosphothreonine.
FT   MOD_RES     504    504       Phosphothreonine.
FT   MOD_RES     635    635       Phosphothreonine; by autocatalysis.
FT   MOD_RES     642    642       Phosphothreonine.
FT   MOD_RES     661    661       Phosphoserine; by autocatalysis.
FT   VAR_SEQ     622    671       RDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGFSY
FT                                TNPEFVINV -> CGRNAENFDRFFTRHPPVLTPPDQEVIR
FT                                NIDQSEFEGFSFVNSEFLKPEVKS (in isoform
FT                                Beta-II).
FT                                /FTId=VSP_004738.
FT   VARIANT     144    144       V -> M (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042304.
FT   VARIANT     496    496       V -> M (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042305.
FT   VARIANT     588    588       P -> H (in dbSNP:rs35631544).
FT                                /FTId=VAR_042306.
FT   CONFLICT     69     69       V -> G (in Ref. 7; CAA44393).
FT   STRAND      342    351
FT   STRAND      354    361
FT   STRAND      364    374
FT   HELIX       375    380
FT   HELIX       384    394
FT   STRAND      406    411
FT   STRAND      413    421
FT   HELIX       428    435
FT   HELIX       440    459
FT   HELIX       469    471
FT   STRAND      472    474
FT   STRAND      480    482
FT   HELIX       505    507
FT   HELIX       510    513
FT   HELIX       521    536
FT   HELIX       546    555
FT   HELIX       566    575
FT   HELIX       590    595
FT   HELIX       598    600
FT   HELIX       605    609
FT   HELIX       629    636
FT   HELIX       646    651
FT   TURN        654    657
SQ   SEQUENCE   671 AA;  76869 MW;  3937E7B667108C68 CRC64;
     MADPAAGPPP SEGEESTVRF ARKGALRQKN VHEVKNHKFT ARFFKQPTFC SHCTDFIWGF
     GKQGFQCQVC CFVVHKRCHE FVTFSCPGAD KGPASDDPRS KHKFKIHTYS SPTFCDHCGS
     LLYGLIHQGM KCDTCMMNVH KRCVMNVPSL CGTDHTERRG RIYIQAHIDR DVLIVLVRDA
     KNLVPMDPNG LSDPYVKLKL IPDPKSESKQ KTKTIKCSLN PEWNETFRFQ LKESDKDRRL
     SVEIWDWDLT SRNDFMGSLS FGISELQKAS VDGWFKLLSQ EEGEYFNVPV PPEGSEANEE
     LRQKFERAKI SQGTKVPEEK TTNTVSKFDN NGNRDRMKLT DFNFLMVLGK GSFGKVMLSE
     RKGTDELYAV KILKKDVVIQ DDDVECTMVE KRVLALPGKP PFLTQLHSCF QTMDRLYFVM
     EYVNGGDLMY HIQQVGRFKE PHAVFYAAEI AIGLFFLQSK GIIYRDLKLD NVMLDSEGHI
     KIADFGMCKE NIWDGVTTKT FCGTPDYIAP EIIAYQPYGK SVDWWAFGVL LYEMLAGQAP
     FEGEDEDELF QSIMEHNVAY PKSMSKEAVA ICKGLMTKHP GKRLGCGPEG ERDIKEHAFF
     RYIDWEKLER KEIQPPYKPK ARDKRDTSNF DKEFTRQPVE LTPTDKLFIM NLDQNEFAGF
     SYTNPEFVIN V
//
